Metabolomics reveals metabolic biomarkers of Crohn's disease

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Jansson, Janet ^a,b   Willing, Ben ^b   Lucio, Marianna ^c   Fekete, Ages ^c   Dicksved, Johan ^b   Halfvarson, Jonas ^d   Tysk, Curt ^d   Schmitt Kopplin, Philippe ^c  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 CARBOXY 2,3 DIHYRO 5,6 DIHYDROINDOLE; 3 (4 HYDROXYPHENYL)PROPIONIC ACID 3 (4 HYDROXYPHENYL)LACTATE; 4 HYDROXYPHENYLACETYLGLYCINE; AMINO ACID; ARACHIDONIC ACID; BILE ACID; CHOLIC ACID; FATTY ACID; GLYCINE; GLYCOCHENODEOXYCHOLIC ACID; GLYCOCHOLIC ACID; INDOLE; LACTIC ACID; LINOLENIC ACID; OLEIC ACID; PALMITIC ACID; PHENYLALANINE; PROSTAGLANDIN E2; PROSTAGLANDIN F1 ALPHA; PROSTAGLANDIN F2 ALPHA; STEARIC ACID; TAUROCHOLIC ACID; TRIHYDROXY 6 BETA CHOLANATE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; ARACHIDONIC ACID METABOLISM; ARTICLE; BILE ACID METABOLISM; BILE ACID SYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE MARKER; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; FECES ANALYSIS; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; METABOLITE; PHENOTYPE; FOURIER ANALYSIS; MASS SPECTROMETRY; METABOLISM;

CROHN DISEASE; FOURIER ANALYSIS; HUMANS; MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 68149099597     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006386     Document Type: Article

References (33)

1. Sartor RB (2006) Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis. Nature Clin Practice Gastroenterol & Hepatology 3: 390-407.
2. Willing B, Halfvarson J, Dicksved J, Rosenquist M, Jarnerot G, et al. (2009) Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis 15: 653-660.
3. Nicholson JK, Holmes E, Wilson ID (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nature Rev Microbiol 3: 431-438.
4. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, et al. (2009) Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 106: 3698-3703.
5. Li M, Wang B, Zhang M, Rantalainen M, Wang S, et al. (2008) Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A 105: 2117-2122.
6. Holmes E, Loo RL, Stamler J, Bictash M, Yap IKS http://www.nature.com/ nature/journal/v453/n7193/full/nature06882.html - a1 http://www.nature.com/nature/journal/v453/n7193/full/nature06882.html- a3et al, Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453: 396-400.
7. Marchesi JR, Holmes H, Khan F, Kochhar S, Scanlan P, et al. (2007) Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 6: 546-551.
8. Saric J, Wang Y, Li J, Coen M, Utzinger J, et al. (2008) Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J Proteome Res 7: 352-360.
9. Rossello-Mora R, Lucio M, Peña A, Brito-Echeverriá J, López-López A, et al. (2008) Metabolic evidence for biogeographic isolation of the extremophilic bacterium Salinibacter ruber. ISME J 2: 242-253.
10. Chen J, Zhao X, Fritsche J, Yin P, Schmitt-Kopplin P, et al. (2008) Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information. Anal Chem 80: 1280-1289.
11. Halfvarson J, Bodin L, Tysk C, Lindberg E, Järnerot G (2003) Inflammatory bowel disease in a Swedish twin cohort: A long-term follow-up of concordance and clinical characteristics. Gastroenterol 124: 1767-1773.
12. Dicksved J, Halfvarson J, Rosenquist M, Järnerot G, Tysk C, et al. (2008) Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J 2: 716-727.
13. Harvey RF, Bradshaw JM (1980) A simple index of Crohn's-disease activity. Lancet 315: 514.
14. Rutgeerts P, Goboes K, Peeters M, Hiele M, et al. (1991) Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338: 771-774.
15. Suhre K, Schmitt-Kopplin P (2008) Masstrix: Mass translator into pathways. Nucleic Acids Research 36: W481-W484.
16. Legendre P, Legendre L (1998) Numerical Ecology. Amsterdam, Elsevier Science 132: 303-304.
17. Dicksved J, Halfvarson J, Rosenquist M, Järnerot G, Tysk C, et al. (2008) JK Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J 2: 716-727.
18. Magro F, Vieira-Coelho MA, Fraga S, Serrão MP, Veloso FT, et al. (2002) Impaired synthesis or cellular storage of norepinephrine, dopamine and 5-hydroxytryptamine in human inflammatory bowl disease. Dig Dis Sci 47: 216-224.
19. Magro F, Cunha E, Araujo F, Meireles E, Pereira P, et al. (2006) Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment. Dig Dis Sci 51: 2039-2044.
20. Sokol H, Pigneur B, Watterlot L, Lakhdari O, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105: 16731-16736.
21. Burczynski ME, Peterson RL, Twine NC, Zuberek KA, Brodeur BJ (2006) Molecular classification of crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. J Mol Diag 8: 51-61.
22. Vang T, Miletic AV, Arimura Y, Tautz L, et al. (2008) Protein tyrosine phosphatases in autoimmunity. Ann Rev Immunology 26: 29-55.
23. Beeken WL (1976) Serum tryptophan in Crohn's-disease. Scand J Gastroenterol 11: 735-740.
24. Baumgart M, Dogan B, Rishniw M, Weitzman G, Bosworth B, et al. (2007) Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J 1: 403-418.
25. Lapidus A, Akerlund JE, Einarsson C (2006) Gallbladder bile composition in patients with crohn's disease. World J Gastroenterol 12: 70-74.
26. Chen F, Ma L, Sartor RB, Li F, Xiong H, et al. (2002) Inflammatory-mediated repression of the rat ileal sodium-dependent bile acid transporter by c-fos nuclear translocation. Gastroenterol 123: 2005-2016.
27. Lowes S, Simmons NL (2001) Human intestinal cell monolayers are preferentially sensitive to disruption of barrier function from basolateral exposure to cholic acid: Correlation with membrane transport and transepithelial secretion. Pflugers Archiv-European J Physiology 443: 265-273.
28. Fernández-Bañares F, Esteve-Comas M, Mañé J, Navarro E, Bertrán X, et al. (1997) Changes in mucosal fatty acid profile in inflammatory bowel disease and in experimental colitis: A common response to bowel inflammation. Clinical Nutrition 16: 177-183.
29. Ramakers JD, Mensink RP, Schaart G, Plat J (2007) Arachidonic acid but not eicosapentaenoic acid (epa) and oleic acid activates nf-kappa b and elevates icam-1 expression in caco-2 cells. Lipids 42: 687-698.
30. Libioulle C, Louis E, Hansoul S, Sandor C, Farnir F, et al. (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. Plos Genet 3: e58.
31. Sheibanie AF, Yen JH, Khayrullina T, Emig F, Zhang M, et al. (2007) The Proinflammatory Effect of Prostaglandin E2 in Experimental Inflammatory Bowel Disease Is Mediated through the IL-23RIL-17 Axis. J Immunolog 178: 8138-8147.
32. Karlsson PC, Huss U, Jenner A, Halliwell B, Bohlin L, et al. (2005) Human Fecal Water Inhibits COX-2 in Colonic HT-29 Cells: Role of Phenolic Compounds. J Nutr 135: 2343-2349.
33. Verberkmoes NC, Russell AL, Shah M, Godzik A, Rosenquist M, et al. (2009) Shotgun metaproteomics of the human distal gut microbiota. ISME J 3: 179-189.